Allucent is a company based in the United States that operates within the manufacturing sector, specifically focusing on pharmaceuticals. Founded in 1994, the company has grown to employ between 1,001 and 5,000 individuals, generating revenue of approximately $361.6 million. Allucent's expertise is reflected in its involvement with regulatory guidance related to medical devices, as evidenced by a published document that discusses the evaluation of sex-specific data in medical device clinical studies. This guidance aims to improve the understanding of safety and effectiveness in medical products, particularly how they may differ in response between women and men. The document indicates that Allucent engages with industry standards and regulatory bodies, such as the FDA, to facilitate discussions and provide recommendations that enhance clinical study designs. Although the document corpus is limited, it suggests that Allucent is actively involved in addressing important considerations in the medical device landscape, particularly regarding gender differences in clinical outcomes.